Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-08-20
1994-04-05
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530395, 530397, 514 12, 514 21, C07K 1514
Patent
active
053004906
ABSTRACT:
This invention relates to a novel anticoagulant substance in human urine, a process for its preparation and a pharmaceutical composition comprising the said substance for the prevention and/or treatment of diseases related to the disorders in blood coagulation system.
REFERENCES:
patent: 3723251 (1973-03-01), Ogawa et al.
patent: 4638050 (1987-01-01), Aoki et al.
patent: 4732891 (1988-03-01), Maki et al.
patent: 4748156 (1988-05-01), Aoki et al.
patent: 4845078 (1989-07-01), Masaoka
patent: 4873222 (1989-10-01), Arai et al.
patent: 5043425 (1991-08-01), Aoki et al.
patent: 5047503 (1991-09-01), Aoki et al.
patent: 5202421 (1993-04-01), Kunihiro et al.
Wen et al.; Human Thrombomodulin: Complete cDNA sequence and chromosome localization of the gene, Biochem., vol. 26, pp. 4350-4357 (1987).
Suzuki et al.; Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation, Embo Journal, vol. 6 (7), pp. 1891-1897 (1987).
Jackman et al.; Human thrombomodulin gene is intron depleted: Nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control, Proc. Nat. Acad. Sci. USA, vol. 84, pp. 6425-6429 (1987).
J. Biochem. 103, 281-285 (1988), Shirai et al.
Thrombosis Research, 37, 353-364 (1985) Aoki et al.
Yoshikawa et al.; "Protection of Endotoxin-Induced Disseminated Intravascular Coagulation in Rats by Gabexate Mesilate"; Kyoto Profectural Univ. of Med.; pp. 633-640.
Ishii et al.; Yakugakkai Abstract 6F05, 11-1, 1988.
Ishii et al.; "Thrombomodulin is Present in Human Plasma and Urine"; J. Clin. Invest., vol. 76, Dec. 1985, pp. 2178-2181.
Palareti et al.; Thrombosis and Haemostasis; "Effects of Gabexate Mesilate, a New Synthetic Serine Protease Inhibitor on Blood Coagulation in Patients with Dic"; Jour. International Soc. on Thrombosis and Haemostasis; No. 1, vol. 58, 1987, p. 420.
Schoendorf et al.; "Endotoxin-Induced Disseminated Intravascular Coagulation in Nonpregnant Rats"; Dept. of OB/GYN; NY School of Med; 1971; pp. 51-58.
Ng et al.; "Pasteurization of Antihemophilic Factor and Model Virus Inactivation Studies"; Thrombosis Research 39; 1985; pp. 439-447.
Zushi et al.; "The Last Three Consecutive Epidermal Growth Factor-Like Structures of Human Thrombomodulin Comprise the Minimum Functional Domain for Protein C-Activating Cofactor Activity and Anticoagulant Activity"; Jour. of Bio. Chem., vol. 264, No. 18, 1989, pp. 10351-10353.
Gomi et al.; "Minimum Functional Domain of Human Thrombomodulin for Protein C Activating Cofactor Activity and Anticoagulant Activity"; Jour. of the International Soc. on Thrombosis and Haemostasis; Thrombosis; Thrombosis and Haemostasis; Abstract 1039; 1989; p. 334.
Maruyama et al.; "Human Thrombomodulin is not an Efficient Inhibitor of the Procoagulant Activity of Thrombin"; J. Clin. Invest.; vol. 75, 1985; pp. 987-991.
Salem et al.; "Isolation and Characterization of Thrombomodulin from Human Placenta"; Jour. Bio. Chem., 1984; vol. 259, No. 19, 1984; pp. 12246-12251.
Suzuki et al.; "Functionally Active Thrombomodulin is Present in Human Platelets"; J. Biochem, 104, 1988, pp. 628-632.
Robbins et al.; "Plasmin and Plasminogen Activators: Kinetics, and Kinetics of Plasminogen Activation"; Annals N.Y. Acad. of Sci., 1981; pp. 588-591.
Kurosawa et al.; "A 10-KDA Cyanogen Bromide Fragment from the Epidermal Growth Factor Homology Domain of Rabbit Thrombomodulin Contains the Primary Thrombin Binding Site"; Jour. Bio. Chem; vol. 263, No. 13, 1988; pp. 5993-5996.
Shirai et al.; "Gene Structure of Human Thrombomodulin, a Cofactor for Thrombin-Catalyzed Activation of Protein C"; J. Biochem., 103, 281, 1988.
Sottrup-Jenson, L. et al.; "The Primary Structure of Human Plasminogen . . ."; Progress in Chemical Fibrinolysis and Thrombolysis, 3, 191, 1978.
Moroz, L. A., "Mini-Plasminogen: A Mechanism for Leukocyte Modulation of Plasminogen Activation by Urokinase", Blood, 58, 97; 1978.
White, W. F. et al.; "The Isolation and Characterization of Plasminogen Activators from Human Urine"; Biochemistry, 5, 2160, 1966.
Bernik, M. B. et al., "Production by Human Tissues in Culture of Immunologically Distinct, Multiple Molecular Weight Forms of Plasminogen Activators"; Annals New York Acad. of Sci.; 593-608, 1981.
Blauhut et al., "Substitution of Antithrombin III in Shock and Dic-A Randomized Study"; Thrombosis Research, vol. 39, No. 1, pp. 81-89, 1985.
Moake, J. L., "Disseminated Intravascular Coagulation"; Current Therapy, pp. 338-339, 1989.
Loscalzo; "Thrombolysis in the Management of Acute Myocardial Infarction and Unstable Angina Pectoris"; Drugs, pp. 192-204; 1985.
Ohno et al., "Fibrinolytic System in Comparison with Heparin or Aprotinin"; Thrombosis Research, vol. 24, No. 5/6, pp. 445-452, 1982.
Triantaphyllopoulos; "Effects of Human Antithrombin III on Mortality and Blood Coagulation Induced in Rabbits by Endotoxin"; Thromb Haemostas, vol. 51, No. 2; pp. 232-235; 1984.
Iosbe, "Inhibitory Effects of Gabexate Mesilate (Foy) on Experimental Dic"; Advanced Exp. Med. Biol., pp. 385-394, 1979.
Emerson, Jr. et al.; "Protection Against Disseminated Intravascular Coagulation and Death by Antithrombin-III in the Escherichia Coli Endotoxemic Rat"; Circulatory Shock; vol. 21; pp. 1-13, 1987.
Diffang et al.; "Effect of Trasylol on Fibrin Deposition and Elimination in the Lungs of Rats with Intravascular Coagulation Induced by Thrombin or Thromboplastin"; Thrombosis Research, vol. 5, pp. 263-276, 1974.
Suzuki, K. et al.; J. Bio. Chem., 264, 4872, 1989.
Rees, M. W., et al.; Chemical Abstracts, 85, 490, Abstract No. 6027r, 1976.
Ichimura Michio
Kunihiro Yasuyuki
Mochida Ei
Ohzawa Nobuo
Tanaka Ryo
Mochida Pharmaceutical Co. Ltd.
Schain Howard E.
LandOfFree
Anticoagulant substance obtained from urine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anticoagulant substance obtained from urine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticoagulant substance obtained from urine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-511064